An economical method of comparing inhaled bronchodilators in reversible diffuse airways obstruction. With special reference to a beta-2 stimulant--salmefamol.
D000328:Adult; D000336:Aerosols; D000402:Airway Obstruction / Q000188:drug therapy*; D000420:Albuterol / Q000008:administration & dosage / Q000627:therapeutic use; D000704:Analysis of Variance; D001993:Bronchodilator Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D004983:Ethanolamines / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007545:Isoproterenol / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D009921:Metaproterenol / Q000008:administration & dosage / Q000627:therapeutic use; D008738:Methyl Ethers / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D010627:Phenethylamines / Q000008:administration & dosage* / Q000628:therapy; D010636:Phenols / Q000008:administration & dosage / Q000627:therapeutic use; D012123:Pulmonary Ventilation; D013147:Spirometry; D013726:Terbutaline / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors
D000336:Aerosols; D001993:Bronchodilator Agents; D004983:Ethanolamines; D008738:Methyl Ethers; D010627:Phenethylamines; D010636:Phenols; D009921:Metaproterenol; D007545:Isoproterenol; D013726:Terbutaline; D000420:Albuterol